Further studies of gene alterations in non-invasive non progressive patient groups and investigations of protein expression are required to clarify the effects of genetic abnormalities of c-myc and CCND1 on progression of TCC. This evidence concerns the gene MYC and tarsal-carpal coalition syndrome.